More than 3,000 U.K. claimants accuse U.S. pharmaceutical giant Johnson & Johnson of knowingly selling asbestos-tainted ...

Johnson & Johnson’s (NYSE:JNJ) earnings report on Tuesday will set the tone for the third quarter pharma earnings, with investors looking for trends, including performance in the MedTech business, ...

Strengthens focus of Johnson & Johnson as an innovation powerhouse and accelerates the portfolio shift of its MedTech Segment to higher-growth and higher-margin markets Standalone orthopaedics ...

The Smashing Machine' went from being a potential Academy Award contender to the biggest failure of Dwayne Johnson's career.

The EPIC study will evaluate treatment with IMAAVY™ versus efgartigimod in adults with gMG and will include a treatment-switch arm The Company also announced new data from the pivotal Vibrance-MG ...

Seven candidates are running for four-year terms on the Allentown School Board, and two candidates are running for a two-year ...

Nanobiotix S.A. has surged on strong NBTXR3 data, but its sole asset is out-licensed to Johnson & Johnson. Learn more about ...

The entrepreneur and former alderman argues reviving the head tax would penalize employers, hurt neighborhood businesses and ...

The biggest accomplishment of these films and others like them, Johnson contends, is that they made women’s suffering ...

Following achievement of the Return Cap, a royalty-only tail period will commence, which entitles HCRx to a predefined, reduced share of royalties not to exceed $14.9 million per year; the tail period ...

Rahul Malhotra is a Weekend News Writer for Collider. From Francois Ozon to David Fincher, he'll watch anything once. He has been writing for Collider for over two years, and has covered everything ...

Smith is a legal veteran who has spent the last three decades advising on real estate matters including acquisitions and ...